| 000 | 01713 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515163528.0 | ||
| 264 | 0 | _c20090615 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a1945-0257 | ||
| 024 | 7 |
_a10.1089/gtmb.2008.0045 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, Shee-Ping | |
| 245 | 0 | 0 |
_aThe association of methylation in the promoter of APC and MGMT and the prognosis of Taiwanese CRC patients. _h[electronic resource] |
| 260 |
_bGenetic testing and molecular biomarkers _cFeb 2009 |
||
| 300 |
_a67-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xtherapeutic use |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDNA Methylation |
| 650 | 0 | 4 |
_aDNA Modification Methylases _xgenetics |
| 650 | 0 | 4 |
_aDNA Repair Enzymes _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xtherapeutic use |
| 650 | 0 | 4 | _aGenes, APC |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTaiwan |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xgenetics |
| 700 | 1 | _aChiu, Sheng-Chun | |
| 700 | 1 | _aWu, Chang-Chieh | |
| 700 | 1 | _aLin, Shinn-Zong | |
| 700 | 1 | _aKang, Jung-Cheng | |
| 700 | 1 | _aChen, Yi-Lin | |
| 700 | 1 | _aLin, Po-Cheng | |
| 700 | 1 | _aPang, Cheng-Yoong | |
| 700 | 1 | _aHarn, Horng-Jyh | |
| 773 | 0 |
_tGenetic testing and molecular biomarkers _gvol. 13 _gno. 1 _gp. 67-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/gtmb.2008.0045 _zAvailable from publisher's website |
| 999 |
_c18746775 _d18746775 |
||